Clinical Trial Update: Recombinant Measles Virus Vaccine Therapy and Oncolytic Virus Therapy in Treating Patients With Progressive, Recurrent, or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating recombinant measles virus vaccine therapy and oncolytic virus therapy for progressive, recurrent, or refractory ovarian epithe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Oncolytic virus therapy (Oncolytic virus therapy)
• recombinant measles virus vaccine therapy (recombinant measles virus vaccine therapy)

Snippet

Sponsor: Mayo Clinic | Conditions: Ovarian Cancer, Primary Peritoneal Cavity Cancer | Phase 1 | Status: COMPLETED | Results posted: 2017-10-02